Electric fields join the fight against advanced lung cancer in major new trial
Disease control
Recruiting now
This study tests whether adding a device that delivers electric fields (TTFields) to standard immunotherapy and chemotherapy can help people with advanced non-small cell lung cancer live longer. About 734 adults with cancer that has spread will be randomly assigned to receive eit…
Phase: PHASE3 • Sponsor: NovoCure GmbH • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC